cbdMD Announces Exclusive Multi-Year Partnership With Amazon Platform Partner Amify
29 Noviembre 2021 - 7:30AM
Business Wire
cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading,
most highly trusted and best recognized CBD companies, today
announced their multi-year exclusive agreement with Amify, an
Amazon.com, Inc. (NASDAQ:AMZN) platform partner, to prepare for the
inclusion of CBD products within the Amazon marketplace. Amify,
which specializes in Amazon go-to-market strategies, content
creation and operational excellence, will act as cbdMD’s exclusive
CBD partner to launch products on the Amazon platform as soon as
the category is accepted and becomes available. This partnership
includes all the leading and award-winning cbdMD branded products,
including cbdMD’s gummies, tinctures, gelcaps and topicals, as well
as the award-winning Paw CBD animal brand. In addition, the new
line of skin care and beauty products under the brand cbdMD
Botanicals will also be available.
Interest in CBD becoming more readily available has grown
exponentially since the passage of the Farm Bill in 2018, and cbdMD
believes Amazon is expected to become a major platform to
distribute CBD products. To prepare for the category inclusion,
cbdMD has worked with Amify to create seller central accounts,
build product pages and other essential components of cbdMD’s
Amazon store and established Amazon launch strategies in order to
fully utilize the Amazon platform. Aside from assisting brands in
effective brand and product marketing with their award-winning
advertising and content, Amify also works to manage storefronts,
oversee the inventory and demand planning and handle customer
service and returns with an expert in-house team. Amify refers to
its unique approach as being a provider of “Amazon-as-a-Service.”
The company is responsible for creating, developing and executing
effective customized Amazon strategies that align with broader
sales and ecommerce goals. With this exclusive partnership, cbdMD
is poised to fully integrate their digital marketing, content
curation and product innovation with the world’s largest online
retailer.
“As an industry, this is the moment we’ve all been waiting for,
and we believe we are close. When a global retailer like Amazon is
ready to accept your products, you get your strategy prepared and
perfected so you’re ready to go to market as soon as possible.
That’s exactly what this partnership represents. We are already one
of the largest online CBD businesses in America, and this
distribution channel will play into our strength. We are excited to
be at the forefront of this category inclusion and we’re taking all
the necessary steps to properly prepare for launch. Whenever that
launch is, we’ll be ready,” said Chairman & Co-CEO Martin
Sumichrast.
About Amify
Amify delivers turnkey, award-winning services to help brands
launch, manage and continually optimize their Amazon channel
strategy. As the first Amazon-as-a-Service provider, we serve as an
outsourced Amazon team, which helps companies own their brand on
the world’s largest ecommerce platform by leveraging cross channel
data to increase sales and improve customer experience. The Amify
team brings vast expertise to sellers, from branding and
advertising to data analytics and business operations. From our
high-performing, beautiful storefronts, to our optimized
forecasting and logistics, we’re an embedded extension of our
client’s team, whose mission is to make it painless for clients to
win on Amazon. Visit GoAmify.com to learn more about their
full-service offerings.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most highly trusted and
recognized cannabidiol (CBD) brands with a comprehensive line of
U.S.-produced, THC-free1 CBD products. Our cbdMD brand currently
includes over 130 SKUs of high-grade, premium CBD products,
including CBD tinctures, CBD gummies, CBD topicals, CBD capsules,
CBD bath bombs, CBD bath salts, CBD sleep aids and CBD drink mixes.
Our Paw CBD brand of pet products includes over 45 SKUs of
veterinarian-formulated products, including tinctures, chews,
topicals products in varying strengths, and our cbdMD Botanicals
brand of beauty and skin care products features 15 SKUs, including
facial oil and serum, toners, moisturizers, clear skin, facial
masks, exfoliants and body care. The company also offers a line of
full spectrum products (approximately 10 SKUs) under its cbdMD
brand. To learn more about cbdMD and their comprehensive line of
U.S.-grown, THC-free1 CBD oil products, please visit www.cbdmd.com,
follow cbdMD on Instagram and Facebook or visit one of the 6,000
retail outlets that carry cbdMD products.
Forward-Looking Statements
This press release contains certain forward-looking statements
that are based upon current expectations and involve certain risks
and uncertainties within the meaning of the U.S. Private Securities
Litigation Reform Act of 1995. Such forward-looking statements can
be identified by the use of words such as ''should,'' ''may,''
''intends,'' ''anticipates,'' ''believes,'' ''estimates,''
''projects,'' ''forecasts,'' ''expects,'' ''plans'' and
''proposes.'' These forward-looking statements are not guarantees
of future performance and are subject to risks, uncertainties, and
other factors, some of which are beyond our control and difficult
to predict and could cause actual results to differ materially from
those expressed or forecasted in the forward-looking statements,
including, without limitation, statements made with respect to the
expansion of the consumer market for CBD products, our ability to
increase our market share, the availability of the Amazon platform
for our CBD products, our ability to expand our business and
significantly increase our revenues, our ability to effectively
leverage our brand partnerships and sponsorships, our ability to
effectively compete in our market, our ability to achieve our net
sales guidance, and our ability to report profitable operations in
the future. You are urged to carefully review and consider any
cautionary statements and other disclosures, including the
statements made under the heading "Risk Factors" in cbdMD, Inc.'s
Annual Report on Form 10-K for the fiscal year ended September 30,
2020 as filed with the Securities and Exchange Commission (the
"SEC") and our other filings with the SEC. All forward-looking
statements involve significant risks and uncertainties that could
cause actual results to differ materially from those in the
forward-looking statements, many of which are generally outside the
control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc.
does not undertake any duty to update any forward-looking
statements except as may be required by law. The information which
appears on our websites and our social media platforms, including,
but not limited to, Instagram and Facebook, is not part of this
press release.
1THC-free is defined as below the level of detection using
validated scientific methods.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211129005376/en/
Public Relations: Robert Pettway Director of Public
Relations rpettway@cbdmd.com (423) 503-5225
Investor Relations: John Weston Director of Investor
Relations john.weston@cbdmd.com (704) 249-9515
cbdMD (AMEX:YCBD)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
cbdMD (AMEX:YCBD)
Gráfica de Acción Histórica
De May 2023 a May 2024